Tony Hagen

Tony Hagen is senior managing editor for The Center for Biosimilars®.

Michigan Trade Group Outlines Best Practices for Biosimilar Adoption

January 13, 2022

Ford Motor saved $5 million by switching patients to 5 biosimilars, and other manufacturers and employers in Michigan have achieved good results with switching programs, the Economic Alliance of Michigan reports.